Inventor · disambiguated record
Ju Yang
Also filed as: YANG JU · Yang ju-ying
55 granted patents·11 pending applications·368 citations·filing 2009–2025
98Inventor score
Top patents by PatentIndex Score
66 records- 0198US11426364B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2020·Granted Aug 30, 2022·10 cites·6 claims
- 0298US9834545B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2016·Granted Dec 5, 2017·26 cites·33 claims
- 0397US11485708B2Compounds for treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Nov 1, 2022·9 cites·21 claims
- 0497US11266643B2Triaryl compounds for treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Mar 8, 2022·13 cites·32 claims
- 0597US11135210B2Indane-amines as PD-L1 antagonistsCHEMOCENTRYX INC·Filed 2020·Granted Oct 5, 2021·10 cites·23 claims
- 0697US10639284B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2017·Granted May 5, 2020·17 cites·30 claims
- 0797US10035768B2C5aR antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Jul 31, 2018·23 cites·10 claims
- 0897US9809581B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2016·Granted Nov 7, 2017·23 cites·29 claims
- 0997US9573897B2C5AR antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Feb 21, 2017·24 cites·9 claims
- 1096US11713307B2Heteroaryl-biphenyl amides for the treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2020·Granted Aug 1, 2023·8 cites·28 claims
- 1196US10919852B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2018·Granted Feb 16, 2021·15 cites·25 claims
- 1296US10568874B2Indane-amines as PD-L1 antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Feb 25, 2020·13 cites·26 claims
- 1396US8906938B2C5aR antagonistsCHEMOCENTRYX INC·Filed 2013·Granted Dec 9, 2014·28 cites·5 claims
- 1495US11708326B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2020·Granted Jul 25, 2023·4 cites·25 claims
- 1595US10660897B2C5aR antagonistsCHEMOCENTRYX INC·Filed 2018·Granted May 26, 2020·6 cites·5 claims
- 1695US9126939B2C5AR antagonistsFAN PINGCHEN·Filed 2011·Granted Sep 8, 2015·30 cites·4 claims
- 1795US8445515B2C5aR antagonistsFAN PINGCHEN·Filed 2009·Granted May 21, 2013·38 cites·25 claims
- 1894US11142521B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Oct 12, 2021·4 cites·6 claims
- 1994US10370363B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2017·Granted Aug 6, 2019·6 cites·13 claims
- 2094US10336736B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2017·Granted Jul 2, 2019·6 cites·24 claims
- 2191US11446289B2Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitorsCHEMOCENTRYX INC·Filed 2019·Granted Sep 20, 2022·3 cites·14 claims
- 2291US10988464B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2019·Granted Apr 27, 2021·3 cites·16 claims
- 2390US11040960B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Jun 22, 2021·3 cites·14 claims
- 2490US9758512B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2016·Granted Sep 12, 2017·6 cites·24 claims
- 2589US10759789B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2019·Granted Sep 1, 2020·2 cites·27 claims
- 2689US10421748B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2018·Granted Sep 24, 2019·3 cites·43 claims
- 2788US8835419B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2012·Granted Sep 16, 2014·9 cites·30 claims
- 2887US11427541B2Salt forms of a complement component C5A receptorCHEMOCENTRYX INC·Filed 2020·Granted Aug 30, 2022·2 cites·32 claims
- 2987US9567323B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2014·Granted Feb 14, 2017·6 cites·9 claims
- 3086US11434230B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2020·Granted Sep 6, 2022·1 cites·14 claims
- 3186US10407417B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Sep 10, 2019·3 cites·12 claims
- 3283US12139475B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2022·Granted Nov 12, 2024·0 cites·4 claims
- 3383US2023102258A1C5ar antagonistsCHEMOCENTRYX INC·Filed 2022·Application pending·0 cites
- 3481US9340509B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2014·Granted May 17, 2016·4 cites·17 claims
- 3580US12371433B2Heteroaryl-biphenyl amines for the treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2023·Granted Jul 29, 2025·0 cites·13 claims
- 3680US9795599B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2016·Granted Oct 24, 2017·2 cites·24 claims
- 3780US9790204B2Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Oct 17, 2017·2 cites·38 claims
- 3879US2025346598A1Heteroaryl-biphenyl amines for the treatment of pd-l1 diseasesCHEMOCENTRYX INC·Filed 2025·Application pending·0 cites
- 3978US11884654B2Substituted anilines as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2021·Granted Jan 30, 2024·0 cites·15 claims
- 4078US10117865B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2017·Granted Nov 6, 2018·1 cites·6 claims
- 4177US9150550B2Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2013·Granted Oct 6, 2015·2 cites·14 claims
- 4277US8685959B2Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonistsCHEMOCENTRYX INC·Filed 2012·Granted Apr 1, 2014·2 cites·45 claims
- 4376US12011439B2Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitorsCHEMOCENTRYX INC·Filed 2022·Granted Jun 18, 2024·0 cites·10 claims
- 4475US11207294B2Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Dec 28, 2021·1 cites·6 claims
- 4574US12497383B2Heteroaryl-biphenyl amides for the treatment of PD-L1 diseasesCHEMOCENTRYX INC·Filed 2023·Granted Dec 16, 2025·0 cites·20 claims
- 4674US11945805B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2021·Granted Apr 2, 2024·0 cites·9 claims
- 4774US11793771B2Immunomodulator compoundsCHEMOCENTRYX INC·Filed 2022·Granted Oct 24, 2023·0 cites·19 claims
- 4874US2021269398A1C5ar antagonistsCHEMOCENTRYX INC·Filed 2020·Application pending·0 cites
- 4973US11820759B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2021·Granted Nov 21, 2023·0 cites·8 claims
- 5073US10786494B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2018·Granted Sep 29, 2020·0 cites·5 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ju Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →